Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc., listed under the ticker HSAQ, is a healthcare-focused special purpose acquisition company operating in the medical device and bioelectronic medicine sector. The company filed a 10-Q with the SEC on August 15, 2022, covering its activities as a publicly traded blank check company. HSAQ completed its initial public offering in 2021, targeting life sciences and medical device opportunities, with Orchestra BioMed representing the combined entity formed around the proposed business combination. Orchestra BioMed's core development work centers on implantable bioelectronic devices designed to treat cardiovascular conditions including hypertension. Visit SpacDesk and sign up for full access to HSAQ's complete filing history, sponsor details, and deal timeline data.